skyepharma Pages on BioPortfolio:

Biotechnology News Skyepharma Search
UPDATE 1-SkyePharma shares surge on hopes for bonds deal ... SkyePharma shares are on the rise this morning after the firm posted a healthy set of ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=s...

SkyePharma: hope worth sharing?
SkyePharma is developing Flutiform, a fixed-dose combination (FDC) of ... Skyepharma originally intended to secure funding by licensing Flutiform, ...
http://www.bioportfolio.com/biotech_news/datamonitor_3.htm...

Biotechnology and Pharmaceutical Industry Search Find Companies ...
UPDATE 1-SkyePharma shares surge on hopes for bonds deal ... SkyePharma stock rises again thanks to Flutiform trials success ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=e...

Biotechnology and Pharmaceutical Industry Search Find Companies ...
TechMARK movers: Refinancing plan whacks Skyepharma. City A.M.: similar . ... UPDATE 1-SkyePharma sets new terms for convertibles. Reuters UK: similar . ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=e...

BioPortfolio - list of techmark companies
TechMARK movers: SkyePharma up on study results . ... TechMARK movers: SkyePharma leads risers SkyePharma is the day's top riser after . ...
http://www.bioportfolio.com/search/list_of_techmark_companie...

Biotechnology and Pharmaceutical Industry Search Find Companies ...
TechMARK movers: Refinancing plan whacks Skyepharma. City A.M.: similar . ... SkyePharma bond renegotiation deal seen 'this week'. Reuters UK: similar . ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=e...

BioPortfolio - SkyePharma
Shares in SkyePharma have plunged since the company announced a ... Skyepharma originally intended to secure funding by licensing Flutiform, but considered ...
http://www.bioportfolio.com/search/SkyePharma.html...

BioPortfolio Press release SkyePharma 2002
Press release SkyePharma 2002 - BioPortfolio. ... Swedish J AOAC Int 2002 SepOct85510649 →View more SkyePharma research Promote your company here ...
http://www.bioportfolio.com/search/Press_release__SkyePharma...

Results from other life science and pharmaceutical sites:

News: SkyePharma PLC -- Interim Results. Genetic Engineering ...
SkyePharma PLC -- Interim Results. Genetic Engineering & Biotechnology News - Biotechnology from Bench to Business. The Leading Publication in Biotechnology
...
http://www.genengnews.com/news/bnitem.aspx?name=41026038...

BioSpace - Skyepharma PLC News, Search Jobs, Events
Company Profile. SkyePharma PLC 105 Piccadilly London W1J 7NJ United Kingdom Phone: 44-207-491-1777 Fax: 44-207-491-3338 SEARCH JOBS. Industry ...
http://www.biospace.com/company_profile.aspx?CompanyId=2927...

King Pharmaceuticals and Skyepharma Announce Licensing Agreement ...
SkyePharma's Geomatrix(R) range of technologies involves a fully- developed, multi-layered tablet technology that controls the release of a product's active
...
http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=...

BioSpace - SkyePharma Inc. News, Search Jobs, Events
SkyePharma Inc. (SKYE) Update on Convertible Bonds and Current Trading 7/8/2008 12:04:06 PM More... GlaxoSmithKline (GSK) and SkyePharma Inc. (SKYE) Gain on ...
http://www.biospace.com/company_profile.aspx?CompanyId=69204...

SkyePharma Reacquires European Rights for DepoBupivacaine(TM)
SkyePharma will also obtain rights to the clinical data from the Phase II trials of DepoBupivacaine(TM). This is expected to simplify the ongoing divestment ...
http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=...

Skyepharma PLC Phase 3 FlutiformTM Study Meets Primary Endpoints ...
3 Jul 2008 ... Ken Cunningham, COO and CEO-designate of SkyePharma, said: "This is the third of the core clinical efficacy trials to meet its primary ...
http://www.biospace.com/news_story.aspx?NewsEntityId=102296...

SkyePharma PLC -- Interim Results: Financial News - Yahoo! Finance
SkyePharma PLC -- Interim Results. - London, UK--(MARKET WIRE)--Aug 28, 2008 -- Interim Results Announcement for the Six Months Ended 30 June 2008 ...
http://biz.yahoo.com/iw/080828/0428841.html...

Skyepharma PLC Announces Flutiform(TM) Phase III Efficacy Study ...
Frank Condella, CEO of SkyePharma, said: "The preliminary results in this Phase III efficacy study represent a key step forward in the development of ...
http://www.biospace.com/news_story.aspx?NewsEntityId=94531...

Home Marketing Services News Reports Company Profiles InDepth Drug Discovery Careers Conferences Videos Search Contact
	Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner. See User Agreement Send comments and feedback to: Peter Barfoot Managing Director, BioPortfolio Ltd. UK Tel: (+44) 1300 321501 USA Voicemail and Fax: (+1) 415 680 2472	All rights reserved. All other trademarks recognized. BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10 Copyright 1997-2008 - BioPortfolio Limited.